Advanced Medical Solutions Updates Share Capital and Voting Rights

Advanced Medical Solutions ( (GB:AMS) ) has shared an update.

Advanced Medical Solutions Group has confirmed that its issued share capital as of 27 February 2026 consists of 219,590,310 ordinary shares of 5p each, all carrying voting rights and with no shares held in treasury. This updated share count serves as the reference point for investors assessing whether they must disclose holdings under U.K. disclosure and transparency rules, providing clarity on the company’s capital structure and governance-related obligations for shareholders.

The most recent analyst rating on (GB:AMS) stock is a Hold with a £247.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.

Advanced Medical Solutions shows strong revenue growth and a solid capital structure, but faces challenges with declining profitability margins. Technical indicators suggest a positive trend, though valuation metrics indicate potential overvaluation. Recent corporate events highlight growth potential through strategic acquisitions and investor engagement.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc is a tissue-healing medical device company focused on adhesives, sealants, biosurgical devices and sutures, aiming to match or surpass market leaders clinically, technically and commercially. Leveraging advanced material science and applicator design, the group targets scalable growth, margin expansion and international reach, particularly in surgical products following its acquisition of Peters Surgical.

Average Trading Volume: 602,316

Technical Sentiment Signal: Buy

Current Market Cap: £464.1M

For a thorough assessment of AMS stock, go to TipRanks’ Stock Analysis page.